Clinical application of 99mTc-methylene diphosphonate bone scanning in senile lung cancer patients

Zhong-yi YANG,Liang GUAN,Wei-jia TIAN,Cheng-mo ZHU

DOI: https://doi.org/10.3969/j.issn.1673-6087.2007.03.012

2007-01-01

Abstract:Objective To evaluate the role of 99mTc,methylene diphosphonate (MDP) bone scanning in determining bone metastasis in the senile lung cancer patients. Methods Ninety patients over 75,years,old with lung cancer was enrolled in this retrospective study. Results Bone metastases were detected in 44 patients (48.89%), negative results were found in 28 patients (31.11%), and degenerations were detected in the other 18 patients (20.00%). The age distribution was significantly different among these three groups(P<0.05). The patients with degeneration lesions were the oldest, while those with negative results were the youngest. The percentages of multiple and isolated bone metastasis were 59.09% and 29.55%. The most common sites of bone metastases were the vertebral column (75.00%), the chest (61.36%), the pelvis (29.55%), the cranial bone(9.09%), and the extremities (6.82%). Conclusions 99mTc,MDP bone scanning is a valuable technique in detecting bone metastasis in the senile lung cancer patients. Degeneration lesions should be excluded while abnormal findings demonstrated.